The Role of Oxytocin and Oxytocin Gene Receptor Methylation During Withdrawal Therapy in Males With Alcohol Use Disorder
Related Experiment Video
Updated: Sep 15, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Phileas J Proskynitopoulos1, Alissa F Haarmeyer1, Stefan Bleich1
1Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Hannover, Germany.
Abstract:
Oxytocin is a promising therapeutic target in the treatment of alcohol use disorder (AUD). However, many studies report contradicting evidence regarding its effect on drug craving, relapse risk and withdrawal symptoms. Epigenetic regulation of the oxytocin and oxytocin receptor (OXTR) gene is altered in several mental disorders and influences social behaviour, often depending on the underlying sex. Evidence suggests that altered promoter methylation could result in oxytocin and OXTR expression differences, thereby possibly influencing drug craving and relapse risk. It is unclear whether promoter methylation changes throughout alcohol withdrawal and is linked to craving and withdrawal symptoms. In this exploratory study, we investigated the effect of 2-week alcohol withdrawal therapy in 99 males on methylation levels (oxytocin and OXTR) compared with 31 healthy controls. We found significantly higher mean methylation values of the OXTR gene in controls than patients across withdrawal (p < 0.001). Regarding oxytocin, we found no differences in mean methylation in healthy controls compared with patients. Across withdrawal, mean methylation decreased in both genes. Fitting a mixed linear model, craving and withdrawal symptoms were associated with changes in methylation levels of the oxytocin gene (p < 0.001), which was also true for the OXTR gene when considering age and smoking as additional covariates. Our study is the first to report an association between AUD, oxytocin and OXTR gene methylation. Methylation of the OXTR gene is reduced in AUD compared with healthy controls, with OT gene methylation linked to craving and withdrawal severity. Our results suggest that investigations of oxytocin as a therapeutic agent need to consider epigenetic regulation of its receptor and gene as a mechanism that could influence oxytocin's effect on craving and withdrawal symptoms.
Insights
This study reveals that alcohol use disorder (AUD) is linked to altered oxytocin receptor (OXTR) gene methylation. Methylation changes in the oxytocin gene correlate with craving and withdrawal severity in AUD patients.
Area of Science:
- Neuroscience
- Genetics
- Psychiatry
Background:
- Oxytocin shows potential for treating alcohol use disorder (AUD), but its effects on craving and withdrawal are debated.
- Epigenetic regulation, specifically DNA methylation of oxytocin and oxytocin receptor (OXTR) genes, influences social behavior and may be altered in mental disorders.
- The role of epigenetic changes in oxytocin and OXTR during alcohol withdrawal and their association with AUD symptoms remains largely unexplored.
Purpose of the Study:
- To investigate the impact of alcohol withdrawal therapy on the methylation levels of the oxytocin and OXTR genes.
- To explore the association between these methylation changes and symptoms of craving and withdrawal in individuals with AUD.
- To determine if OXTR gene methylation differs between individuals with AUD and healthy controls.
Main Methods:
- An exploratory study involving 99 males undergoing 2-week alcohol withdrawal therapy and 31 healthy male controls.
- Analysis of methylation levels in the promoter regions of the oxytocin and OXTR genes.
- Statistical modeling (mixed linear models) to assess the relationship between gene methylation, withdrawal duration, craving, and withdrawal symptoms, considering covariates like age and smoking status.
Main Results:
- Significantly lower mean methylation values of the OXTR gene were observed in patients with AUD compared to healthy controls (p < 0.001).
- No significant differences in oxytocin gene methylation were found between the AUD group and controls.
- Mean methylation levels for both oxytocin and OXTR genes decreased during the 2-week withdrawal period.
- Craving and withdrawal symptoms were significantly associated with changes in oxytocin gene methylation (p < 0.001).
- OXTR gene methylation changes were also linked to craving and withdrawal severity when age and smoking were included as covariates.
Conclusions:
- This is the first study to demonstrate a direct association between alcohol use disorder, oxytocin, and OXTR gene methylation.
- Reduced OXTR gene methylation in AUD patients compared to controls suggests a potential epigenetic mechanism.
- Oxytocin gene methylation is significantly linked to the severity of craving and withdrawal symptoms in AUD.
- Future research on oxytocin as an AUD therapeutic should consider the epigenetic regulation of oxytocin and its receptor as a key factor influencing treatment efficacy.
More Related Videos
05:12Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
Related Concept Videos
CNS Depressants: Alcohol and Nicotine
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Drug Dependence
Neurotransmitters
Drug Abuse and Addiction: Pharmacological Phenomena
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...